Susan J. Johns

3.2k total citations
33 papers, 2.3k citations indexed

About

Susan J. Johns is a scholar working on Oncology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Susan J. Johns has authored 33 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Clinical Biochemistry. Recurrent topics in Susan J. Johns's work include Drug Transport and Resistance Mechanisms (24 papers), Metabolism and Genetic Disorders (9 papers) and Amino Acid Enzymes and Metabolism (8 papers). Susan J. Johns is often cited by papers focused on Drug Transport and Resistance Mechanisms (24 papers), Metabolism and Genetic Disorders (9 papers) and Amino Acid Enzymes and Metabolism (8 papers). Susan J. Johns collaborates with scholars based in United States, Japan and Russia. Susan J. Johns's co-authors include Kathleen M. Giacomini, Thomas E. Ferrin, Michiko Kawamoto, Doug Stryke, Conrad C. Huang, Elaine J. Carlson, Travis R. Taylor, Ira Herskowitz, Joseph DeYoung and Andrew G. Clark and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Pharmacological Reviews.

In The Last Decade

Susan J. Johns

33 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan J. Johns United States 23 1.4k 733 656 324 306 33 2.3k
Michiko Kawamoto United States 17 1.1k 0.8× 451 0.6× 523 0.8× 266 0.8× 272 0.9× 27 1.7k
Koen van de Wetering Netherlands 32 1.4k 1.0× 976 1.3× 517 0.8× 282 0.9× 160 0.5× 54 3.1k
Conny Bakker Netherlands 17 1.2k 0.9× 1.3k 1.8× 1.7k 2.6× 388 1.2× 139 0.5× 27 3.0k
Marie V. St–Pierre Switzerland 24 987 0.7× 552 0.8× 489 0.7× 185 0.6× 83 0.3× 43 1.9k
Kelly Bleasby United States 16 674 0.5× 240 0.3× 349 0.5× 236 0.7× 165 0.5× 21 1.1k
Yasuna Kobayashi Japan 19 784 0.6× 350 0.5× 334 0.5× 267 0.8× 97 0.3× 51 1.4k
Stephen D. Zucker United States 26 362 0.3× 1.2k 1.7× 865 1.3× 129 0.4× 125 0.4× 60 2.3k
Maria L.H. Vlaming Netherlands 21 994 0.7× 328 0.4× 479 0.7× 272 0.8× 102 0.3× 30 1.4k
Alice A. Gibson United States 23 790 0.6× 391 0.5× 261 0.4× 213 0.7× 99 0.3× 46 1.4k
Roberto Mazzanti Italy 27 820 0.6× 820 1.1× 209 0.3× 144 0.4× 81 0.3× 77 2.8k

Countries citing papers authored by Susan J. Johns

Since Specialization
Citations

This map shows the geographic impact of Susan J. Johns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan J. Johns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan J. Johns more than expected).

Fields of papers citing papers by Susan J. Johns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan J. Johns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan J. Johns. The network helps show where Susan J. Johns may publish in the future.

Co-authorship network of co-authors of Susan J. Johns

This figure shows the co-authorship network connecting the top 25 collaborators of Susan J. Johns. A scholar is included among the top collaborators of Susan J. Johns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan J. Johns. Susan J. Johns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morrissey, Kari M., et al.. (2012). The UCSF-FDA TransPortal: A Public Drug Transporter Database. Clinical Pharmacology & Therapeutics. 92(5). 545–546. 126 indexed citations
2.
Yee, Sook Wah, Lijun Xu, Congcong Wen, et al.. (2012). Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3. The Pharmacogenomics Journal. 13(2). 110–120. 67 indexed citations
3.
Kim, Myeong‐Jin, Peter Skewes-Cox, Stephanie Hesselson, et al.. (2011). Functional Characterization of Liver Enhancers That Regulate Drug-Associated Transporters. Clinical Pharmacology & Therapeutics. 89(4). 571–578. 18 indexed citations
4.
Choi, Ji Ha, Sook Wah Yee, Mee J. Kim, et al.. (2009). Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1. Pharmacogenetics and Genomics. 19(10). 770–780. 45 indexed citations
5.
Chen, Ying, Shuanglian Li, Sook Wah Yee, et al.. (2009). Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function. The Pharmacogenomics Journal. 9(2). 127–136. 85 indexed citations
6.
Abla, Nada, Leslie W. Chinn, Tsutomu Nakamura, et al.. (2008). The Human Multidrug Resistance Protein 4 (MRP4, ABCC4): Functional Analysis of a Highly Polymorphic Gene. Journal of Pharmacology and Experimental Therapeutics. 325(3). 859–868. 88 indexed citations
7.
Yee, Sook Wah, James E. Shima, Stephanie Hesselson, et al.. (2008). Identification and Characterization of Proximal Promoter Polymorphisms in the Human Concentrative Nucleoside Transporter 2 (SLC28A2). Journal of Pharmacology and Experimental Therapeutics. 328(3). 699–707. 23 indexed citations
8.
Urban, Thomas, Chen Yang, Leah L. Lagpacan, et al.. (2007). Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4). Pharmacogenetics and Genomics. 17(9). 773–782. 40 indexed citations
9.
Badagnani, Ilaria, Marco D. Sorani, Robert H. Edwards, et al.. (2006). PharmGKB Submission Update: VI. PMT Submissions of Genetic Variations in Neurotransmitter Transporters (SLC6, SLC17, and SLC18) to the PharmGKB Network. Pharmacological Reviews. 58(1). 5–6. 2 indexed citations
10.
Gow, Jason M., Leslie W. Chinn, Libusha Kelly, et al.. (2006). PharmGKB Submission Update: IV. PMT Submissions of Genetic Variations in ATP-Binding Cassette Transporters to the PharmGKB Network. Pharmacological Reviews. 58(1). 1–2. 15 indexed citations
11.
Badagnani, Ilaria, Richard A. Castro, Travis R. Taylor, et al.. (2006). Interaction of Methotrexate with Organic-Anion Transporting Polypeptide 1A2 and Its Genetic Variants. Journal of Pharmacology and Experimental Therapeutics. 318(2). 521–529. 145 indexed citations
12.
Owen, Ryan, Leah L. Lagpacan, Travis R. Taylor, et al.. (2005). FUNCTIONAL CHARACTERIZATION AND HAPLOTYPE ANALYSIS OF POLYMORPHISMS IN THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER, ENT2. Drug Metabolism and Disposition. 34(1). 12–15. 30 indexed citations
13.
Owen, Ryan, Jennifer H. Gray, Travis R. Taylor, et al.. (2005). Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2. Pharmacogenetics and Genomics. 15(2). 83–90. 42 indexed citations
14.
Erdman, Andrew R., Lara M. Mangravite, Thomas Urban, et al.. (2005). The human organic anion transporter 3 (OAT3;SLC22A8): genetic variation and functional genomics. American Journal of Physiology-Renal Physiology. 290(4). F905–F912. 78 indexed citations
15.
Fujita, Tomoe, Chaline Brown, Elaine J. Carlson, et al.. (2005). Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenetics and Genomics. 15(4). 201–209. 81 indexed citations
16.
Badagnani, Ilaria, R A Castro, Christopher M. A. Brett, et al.. (2005). Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3). The Pharmacogenomics Journal. 5(3). 157–165. 42 indexed citations
17.
Gray, Jennifer H., Lara M. Mangravite, Ryan Owen, et al.. (2004). Functional and Genetic Diversity in the Concentrative Nucleoside Transporter, CNT1, in Human Populations. Molecular Pharmacology. 65(3). 512–519. 70 indexed citations
18.
Shu, Yan, Maya K. Leabman, Bo Feng, et al.. (2004). PharmGKB Update: III. Genetic Variants of SLC22A1, Solute Carrier Family 22 (Organic Cation Transporter), Member 1. Pharmacological Reviews. 56(2). 161–161. 4 indexed citations
19.
Kroetz, Deanna L., Christiane Pauli‐Magnus, Laura M. Hodges, et al.. (2003). Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics. 13(8). 481–494. 352 indexed citations
20.
Arnold, Gregory E., et al.. (1992). Use of conditional probabilities for determining relationships between amino acid sequence and protein secondary structure. Proteins Structure Function and Bioinformatics. 12(4). 382–399. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michiko Kawamoto Breakdown of academic impact, for papers by Koen van de Wetering Breakdown of academic impact, for papers by Conny Bakker Breakdown of academic impact, for papers by Marie V. St–Pierre Breakdown of academic impact, for papers by Kelly Bleasby Breakdown of academic impact, for papers by Yasuna Kobayashi Breakdown of academic impact, for papers by Stephen D. Zucker Breakdown of academic impact, for papers by Maria L.H. Vlaming Breakdown of academic impact, for papers by Alice A. Gibson Breakdown of academic impact, for papers by Roberto Mazzanti
Rankless by CCL
2026